Trait Biosciences
PrivateLast Round
Early Funding
Oct 11, 2023
Total Funding Raised
$34.61M
Company Overview
Trait Biosciences operates in Healthcare & Life Sciences and is based in Santa Fe, New Mexico. Its latest recorded funding round was an Early Funding round in October 2023.
Trait Biosciences is a biotechnology company that develops proprietary science-based solutions to make cannabinoids water-soluble for use in consumer products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trait Biosciences Comparables
Compare Trait Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SōRSE Technology | 89% | |
| Vertosa | 88% | |
| Landrace Bioscience, Inc. | 86% |
For institutional investors. Book with your work email.
Trait Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 11, 2023 | ||||
| Series A | Jun 16, 2021 | ||||
| Seed | Sep 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trait Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gotham Green Partners | Series A, Early Funding |
| Btomorrow Ventures | Series A, Early Funding |
| BTV | Series A |
| Green Acre Capital | Seed |
| CannaIncome Fund Corp. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2025
Will exhibit at Discovery & Development US 2025 in October 2025.
- May 16, 2024
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 14, 2026
Trait Biosciences Inc. continues to advance its proprietary water-soluble cannabinoid technology platform, which converts CBD into water-soluble forms such as CBD82S(TM) to improve absorption and bioavailability while supporting flexible formulation and delivery.
For institutional investors. Book with your work email.
Trait Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trait Biosciences's valuation, stock price, and market status.
Is Trait Biosciences a public or private company?
Trait Biosciences is a private company.
What is the current stock price of Trait Biosciences?
Trait Biosciences is a private company, so its shares have no public market price. Caplight tracks Trait Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trait Biosciences worth (valuation)?
Valuation information for Trait Biosciences is not publicly available.
Can I buy Trait Biosciences stock?
Trait Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trait Biosciences's last funding round?
Trait Biosciences's most recent funding round was Early Funding on October 11, 2023.
Who are the main investors in Trait Biosciences?
Key investors in Trait Biosciences include Gotham Green Partners, Btomorrow Ventures, BTV.
Will Trait Biosciences IPO soon?
No public IPO plans have been announced for Trait Biosciences.
How can I track Trait Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Trait Biosciences's shares on secondary markets.